UK markets closed

Immunome, Inc. (IMNM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
14.92-1.12 (-6.98%)
At close: 04:00PM EDT
14.92 0.00 (0.00%)
After hours: 07:32PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
14,018
0
0
0
-
Operating expenses
Research development
23,405
23,089
23,272
14,110
7,486
-
Selling general and administrative
13,553
19,657
13,629
11,094
4,775
-
Total operating expenses
36,958
42,746
36,901
25,204
12,261
-
Operating income or loss
-36,958
-28,728
-36,901
-25,204
-12,261
-
Interest expense
-
-
-
10
38
106
Total other income/expenses net
-
-80,802
-
503
-5,538
-
Income before tax
-36,962
-106,806
-36,896
-24,711
-17,837
-
Income from continuing operations
-36,962
-106,806
-36,896
-24,711
-17,837
-
Net income
-36,962
-106,806
-36,896
-24,711
-17,837
-
Net income available to common shareholders
-37,584
-106,806
-37,518
-24,711
-17,837
-
Basic EPS
-1.80
-
-3.09
-2.14
-5.26
-1.82
Diluted EPS
-1.80
-
-3.09
-2.14
-5.26
-1.82
Basic average shares
12,178
-
12,127
11,539
3,390
5,744
Diluted average shares
12,178
-
12,127
11,539
3,390
5,744